000 01466 a2200433 4500
005 20250512081533.0
264 0 _c19860402
008 198604s 0 0 eng d
022 _a0022-1899
024 7 _a10.1093/infdis/153.3.628
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTelzak, E
245 0 0 _aClinical evaluation of the immunoadjuvant murabutide, a derivative of MDP, administered with a tetanus toxoid vaccine.
_h[electronic resource]
260 _bThe Journal of infectious diseases
_cMar 1986
300 _a628-33 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650 0 4 _aAcetylmuramyl-Alanyl-Isoglutamine
_xadministration & dosage
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAntibody Formation
650 0 4 _aDouble-Blind Method
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aFemale
650 0 4 _aHemagglutination Tests
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aTetanus Toxoid
_xadministration & dosage
700 1 _aWolff, S M
700 1 _aDinarello, C A
700 1 _aConlon, T
700 1 _ael Kholy, A
700 1 _aBahr, G M
700 1 _aChoay, J P
700 1 _aMorin, A
700 1 _aChedid, L
773 0 _tThe Journal of infectious diseases
_gvol. 153
_gno. 3
_gp. 628-33
856 4 0 _uhttps://doi.org/10.1093/infdis/153.3.628
_zAvailable from publisher's website
999 _c3956129
_d3956129